洛伦德罗斯塔特在失控高血压中的有效性和安全性:系统性审查和元分析
Allah Dad1, Kinza Bakht1, Haris Bin Tahir2
1Sheikh Zayed Medical College/Hospital, Rahim Yar Khan, Pakistan.
Journal of clinical hypertension (Greenwich, Conn.)
|September 24, 2025
概括
洛伦德罗斯塔特有效地降低了不控制高血压的成年人的血压,降低了心缩和心缩读数. 虽然它通常是安全的,但它增加了高血和低血的风险,需要仔细监测.
科学领域:
- 心血管医学 心血管医学
- 临床药理学 临床药理学
背景情况:
- 失控的高血压带来了重大的心血管风险.
- 需要新的治疗药物来改善血压管理.
- 洛伦德洛斯塔特是抗性高血压的潜在治疗选择.
研究的目的:
- 系统地审查和元分析罗伦德罗斯塔特在非控制高血压的成年人中的疗效和安全性.
- 为了评估洛伦德罗斯塔特对心压和心压血压的影响.
- 评估与洛伦德洛斯塔特治疗相关的不良事件.
主要方法:
- 按照PRISMA指南进行系统审查和元分析.
- 搜索了五个数据库,查找随机对照试验 (RCT),比较洛伦德罗斯与安慰剂.
- 包括1568名参与者参加的三项RCT;主要结局是静脉压变化 (SBP).
主要成果:
- 洛伦德洛斯塔特显著降低了24小时的门诊SBP (MD: -7.45 mmHg) 和腹筋BP (MD: -3.49 mmHg).
- 观察到严重升高的血压事件显著减少 (OR:0.37).
- 发现高胆固醇血量 (OR:3.22) 和低胆固醇血量 (OR:2.16) 的风险增加;严重不良事件没有显著差异.
结论:
- 洛伦德洛斯塔特在控制不良的高血压中显著有效降低门诊和透气血压.
- 这种药物具有一般可容忍的安全性,但高胆血和低胆血是关键风险.
- 建议进行进一步的长期试验,以确认持续的疗效和安全性.
相关概念视频
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
433
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
433
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
869
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
869
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
556
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
556
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.2K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.2K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.4K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.2K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.2K